Nebenwirkungen · Tasmar
Tasmar 100 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-086582 · Präparat HOS-083306
8 General disorders and Common Chest pain administration site conditions Influenza like illness Hepatobiliary disorders Uncommon Hepatocellular injury, in rare cases with fatal outcome* (see section 4.4) Investigations Common Increase of alanine aminotransferase (ALT) * Adverse reactions for which no frequency could be derived from clinical studies (i.e. where a specific adverse reaction was not observed in clinical trials but was reported post-marketing only) are indicated by an asterisk (*), and the frequency category has been calculated according to EU Guideline.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-09-10T13:49:00Z · SHA-256 8ce859140f9a095e62d5fef3a3e25bd89320c57ae3e287a376abb5c14d6c4437 · Passage ecce4bce6cdedf052071fc2d186a79674eebcd9dbdc5e628e136add9e5264f62 · Zeichen 3836–4686 im Abschnitt